PUBLISHER: The Business Research Company | PRODUCT CODE: 1427992
PUBLISHER: The Business Research Company | PRODUCT CODE: 1427992
A regulatory information management system is a centralized software platform designed to streamline the tracking of product applications and registrations within the regulatory industry. It facilitates the tracking and recording of regulatory processes from initiation to completion, catering to various segments such as pharmaceuticals, biologics, and cosmetics.
The main components utilized in regulatory information management systems include solutions and services. Software solutions are designed to address specific client problems, and deployment options encompass on-premises and cloud-based solutions. These systems are applicable to enterprises of various sizes, including small and medium enterprises as well as large enterprises. The applications covered by these systems include registration management, regulatory intelligence, labeling management, submission planning and tracking management, publishing, document management, and others. These applications find use across various end-users, including the pharmaceutical sector, medical device sector, and others.
The regulatory information management system market research report is one of a series of new reports from The Business Research Company that provides regulatory information management system market statistics, including regulatory information management system industry global market size, regional shares, competitors with a regulatory information management system market share, detailed regulatory information management system market segments, market trends and opportunities, and any further data you may need to thrive in the regulatory information management system industry. This regulatory information management system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The regulatory information management system market size has grown rapidly in recent years. It will grow from $1.79 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The increase observed in the historical period can be attributed to factors such as stringent regulatory compliance requirements, the growth of the pharmaceutical industry, the globalization of supply chains, an increasing volume of regulatory data, and a heightened emphasis on data security.
The regulatory information management system market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The anticipated growth in the forecast period can be attributed to the integration with artificial intelligence (AI), the increased complexity of the regulatory landscape, the expansion of Regulatory Information Management Systems (RIMS) in emerging markets, the demand for cloud-based solutions, and a focus on real-time regulatory monitoring. Significant trends expected during the forecast period include advancements in technology, collaboration and integration with external partners, the adoption of blockchain technology for data integrity, mobile access and user-friendly interfaces, as well as the utilization of cross-functional collaboration platforms.
The substantial increase in the number of clinical trials is a key driver of the regulatory information management system market's growth. Clinical trials involve the use of individuals as subjects for various interventions, and the regulatory information management system plays a crucial role in tracking, managing, and simplifying the evolving regulatory requirements and complexities associated with these trials. Notably, data from the World Health Organization (WHO) in February 2023 revealed a rise in clinical trials in Southeast Asia from 10,966 in 2021 to 11,030 in 2022. Additionally, clinical trials in Africa increased from 905 in 2020 to 1,078 in 2021. This surge in clinical trials underscores the increasing demand for regulatory information management systems to efficiently handle regulatory aspects.
The continuous growth of digitization is expected to be a significant driver of the regulatory information management system market. Digitization, involving the conversion of analog information into digital data, is increasingly leveraging regulatory information management systems (RIMS) to streamline the management of regulatory data, compliance documentation, and submissions. According to data from Augusta Free Press in December 2022, global spending on digital transformation reached about $1.85 trillion, reflecting a 16% increase from the previous year. This shift toward digitization is a pivotal factor driving the adoption of regulatory information management systems.
A noteworthy trend is the emphasis on product innovations by major companies. To maintain a competitive edge, these companies are launching innovative products tailored to the unique demands of the life sciences and medical device sectors. For instance, in February 2023, ArisGlobal, LLC introduced the Investigational Product Regulatory Information Management System (RIMS), a pre-validated turnkey solution designed to meet the specific needs of life sciences and medical device firms during the research and development stages of drug development. This product incorporates features such as clinical trial authorization tracking, investigational submission and dossier planning, and health authority commitment management to enhance efficiency and compliance.
Strategic partnerships are playing a crucial role in simplifying the adoption of efficient sharing of regulatory information in the regulatory information management system market. Companies are leveraging strategic partnerships to enhance their strengths and resources for mutual benefits and success. For instance, in August 2023, Vitality TechNet Inc. partnered with Fluree, aiming to enable pharmaceutical regulatory information management and expedite drug discovery processes.
In May 2023, Ennov, a France-based provider of content and data management software for the life sciences industry, acquired Samarind Limited, a UK-based provider of regulatory information management (RIM) software and services. This strategic acquisition enriches Ennov's position in the regulatory information management system market, particularly in the medical device sector.
Major companies operating in the regulatory information management system market report are Deloitte Touche Tohmatsu Limited, DXC Technology Company, IQVIA Inc., Wipro Ltd., Parexel International Corporation, Korber Pharma, Veeva Systems Inc., Dovel Technologies Inc., Calyx, ArisGlobal LLC, DDi Inc., NNIT A/S, Freyr Software Services Private Limited, Navitas Life Sciences, MasterControl Solutions Inc., Sparta Systems Inc., Instem PLC, Phlexglobal Ltd., Ennov SA, LORENZ Life Sciences Group, Extedo GmbH, Gimmal, Dot Compliance Ltd., Kalypso LP, Rimsys Inc., Virtify Inc., Glemser Technologies Corporation, RegDesk, AmpleLogic, Ithos Global Inc.
North America was the largest region in the regulatory information management system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the regulatory information management system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the regulatory information management system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The regulatory information management system market consists of revenues earned by providing services such as data management, dossier management, product registration lifecycle management services, and easy-to-configure dashboards and reports. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Regulatory Information Management System Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on regulatory information management system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for regulatory information management system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The regulatory information management system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of covid 19 on supply chains and consumption patterns.